Skip to main content

Table 1 Baseline characteristics of the study subjectsa

From: Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial

Variable

Flaxseed oil (n = 21)

Placebo (n = 19)

P valuec

Age (years)

55.67 (6.9)

54.80 (7.8)

0.708

Sexd(%)

 Male

19 (90.5)

17 (89.5)

0.916

 Female

2 (9.5)

2 (10.5)

Weight (kg)

86.02 (10.70)

85.66 (10.19)

0.915

Body mass index (kg/m2)

30.36 (3.04)

30.70 (3.90)

0.766

Waist circumference (cm)

104.42 (7.68)

107.29 (8.63)

0.305

Neck circumference (cm)

41.08 (2.53)

41.71 (3.88)

0.576

CAD duration (years)

2.6 (1.1)

2.8 (1.7)

0.618

Medication (%)

 Statin

21 (100)

19 (100)

1.000d

 Aspirin

21 (100)

19 (100)

1.000d

 Anti-hypertensive drugs

18 (85.7)

15 (78.9)

0.689d

SBP (mmHg)

116.62 (12.13)

112.50 (15.09)

0.352

DBP (mmHg)

75.72 (8.51)

79.59 (10.14)

0.216

Smoking (%)

 Yes

1 (4.8)

3 (15.8)

0.331d

 No

20 (95.2)

16 (84.2)

Physical activity (METs)b

539.74 (45, 2628)

537.95 (99, 1920)

0.991

  1. CAD coronary artery diseases, SBP systolic blood pressure, DBP diastolic blood pressure, METs metabolic equivalents
  2. aValues are expressed as mean (SD)
  3. bValues are expressed as geometric mean (minimum, maximum) and p-value are estimated after log-transformation
  4. cIndependent samples t-test
  5. dValues are expressed as frequency (%) and P value based on chi-square test